BioMarin Pharmaceutical | BMRN - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Bayer EUR 1.62B 529M 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 6.66B 4.99B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06